John Bartlett
John Bartlett
Director of Transformative Pathology, Ontario Institute for Cancer Research
Verified email at - Homepage
Cited by
Cited by
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practiceá…
AC Wolff, MEH Hammond, DG Hicks, M Dowsett, LM McShane, ...
Archives of Pathology and Laboratory Medicine 138 (2), 241-256, 2013
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group
M Dowsett, TO Nielsen, R A’Hern, J Bartlett, RC Coombes, J Cuzick, ...
Journal of the National cancer Institute 103 (22), 1656-1664, 2011
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ...
Cell 161 (7), 1681-1696, 2015
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
Comprehensive molecular characterization of muscle-invasive bladder cancer
AG Robertson, J Kim, H Al-Ahmadie, J Bellmunt, G Guo, AD Cherniack, ...
Cell 171 (3), 540-556. e25, 2017
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
A short history of the polymerase chain reaction
JMS Bartlett, D Stirling
PCR protocols, 3-6, 2003
Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer
CJ Witton, JR Reeves, JJ Going, TG Cooke, JMS Bartlett
The Journal of Pathology: A Journal of the Pathological Society of Greatá…, 2003
Integrated genomic characterization of pancreatic ductal adenocarcinoma
BJ Raphael, RH Hruban, AJ Aguirre, RA Moffitt, JJ Yeh, C Stewart, ...
Cancer cell 32 (2), 185-203. e13, 2017
Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations
G Sauter, J Lee, JMS Bartlett, DJ Slamon, MF Press
Journal of Clinical Oncology 27 (8), 1323-1333, 2009
Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline focused update
AC Wolff, MEH Hammond, KH Allison, BE Harvey, PB Mangu, ...
Archives of pathology & laboratory medicine 142 (11), 1364-1382, 2018
An international Ki67 reproducibility study
MYC Polley, SCY Leung, LM McShane, D Gao, JC Hugh, ...
Journal of the National Cancer Institute, djt306, 2013
Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients
HR Ali, E Provenzano, SJ Dawson, FM Blows, B Liu, M Shah, HM Earl, ...
Annals of Oncology 25 (8), 1536-1543, 2014
Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer
J Edwards, NS Krishna, KM Grigor, JMS Bartlett
British journal of cancer 89 (3), 552-556, 2003
Multidisciplinary meeting on male breast cancer: summary and research recommendations
LA Korde, JA Zujewski, L Kamin, S Giordano, S Domchek, WF Anderson, ...
Journal of Clinical Oncology 28 (12), 2114-2122, 2010
Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial
CJH Van de Velde, D Rea, C Seynaeve, H Putter, A Hasenburg, ...
The Lancet 377 (9762), 321-331, 2011
A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns
F Notta, M Chan-Seng-Yue, M Lemire, Y Li, GW Wilson, AA Connor, ...
Nature, 2016
AKT activation predicts outcome in breast cancer patients treated with tamoxifen
T Kirkegaard, CJ Witton, LM McGlynn, SM Tovey, B Dunne, A Lyon, ...
The Journal of pathology 207 (2), 139-146, 2005
Evaluating HER2 amplification and overexpression in breast cancer
J Bartlett, JJ Going, EA Mallon, AD Watters, JR Reeves, P Stanton, ...
The Journal of pathology 195 (4), 422-428, 2001
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
B Asselain, W Barlow, J Bartlett, J Bergh, E Bergsten-Nordstr÷m, J Bliss, ...
The Lancet Oncology 19 (1), 27-39, 2018
The system can't perform the operation now. Try again later.
Articles 1–20